Amit M Oza, BSc, MD, MBBS, FRCPC

Dr. Amit Oza is Head of the Division of Medical Oncology & Hematology, and Medical Director of the Cancer Clinical Research Unit at Princess Margaret (PM) Cancer Centre. He is also co-Director of the Drug Development Program at PM Cancer Centre, Scientist at the Ontario Cancer Institute, and Professor of Medicine at University of Toronto. Dr. Oza has been PI and co-investigator in >100 phase I, II and III trials for gynecological cancer and advanced colorectal malignancies. He is the past co-chair of the National Cancer Institute Gynecologic Cancer Steering Committee, and Executive Member of the international Gynecologic Cancer InterGroup. Under his direction, the gynecology group is one of the largest ovarian cancer (OC) clinical trials groups consistently accruing >30% of all patients seen onto clinical trials (>120/yr) at PM Cancer Centre. Under his direction the group has participated or led seminal studies in gynecologic cancers that have led to the approval or use of targeted agents such as PARP inhibitors (olaparib, niraparib) and anti-angiogenic agents (bevacizumab) internationally. Since 2011, he has obtained >$36.9M in peer-reviewed funding and has published >180 articles (all types) in journals, including the New England Journal of Medicine (IF=53); Lancet Oncology (IF=16), and the Journal of Clinical Oncology (IF=16.4).

J Clin Oncol. 1998 Mar;16(3):1122-30
Siu LL, Oza AM, Eisenhauer EA, Firby PS, Thiessen JJ, Michael M, Wainman N, Manzo J, Feld R, Goldberg RA, Moore MJ
J Clin Oncol. 1997 Mar;15(3):1000-7
Doyle C, Stockler M, Pintilie M, Panesar P, Warde P, Sturgeon J, Oza AM
Cancer J Sci Am. 1996 Jul-Aug;2(4):202-4
Bloomfield DJ, Oza AM
Ann Hematol. 1995 Jul;71(1):35-9
MacCallum PK, Rohatiner AZ, Davis CL, Whelan JS, Oza AM, Lim J, Love S, Amess JA, Leahy M, Gupta RK
Cancer Res. 1994 Oct 1;54(19):5101-5
Oza AM, Tonks S, Lim J, Fleetwood MA, Lister TA, Bodmer JG
Ann Oncol. 1994 Apr;5(4):343-7
Oza AM, ten Bokkel Huinink W, Dubbelman R, Soepenberg O, Mandjes I, Aartsen E, McVie JG
Hematol Oncol Clin North Am. 1994 Feb;8(1):1-14
Oza AM, Tannock IF
Ann Oncol. 1993 May;4(5):385-92
Oza AM, Ganesan TS, Leahy M, Gregory W, Lim J, Dadiotis L, Barbounis V, Jones AE, Amess J, Stansfeld AG
Br J Haematol. 1993 Mar;83(3):404-11
Davis CL, Rohatiner AZ, Lim J, Whelan JS, Oza AM, Amess J, Love S, Stead E, Lister TA
Epidemiol Rev. 1993;15(1):196-208
Oza AM, Boyd NF



Co-director, Robert and Maggie Bras and Family Drug Development Program​
Professor, Department of Medicine, University of Toronto
Head, Department of Medical Oncology & Hematology